Suven Life Sciences trades in fine fettle on the bourses

13 Nov 2017 Evaluate

Suven Life Sciences is currently trading at Rs. 202.75, up by 4.70 points or 2.37 % from its previous closing of Rs. 198.05 on the BSE.

The scrip opened at Rs. 201.60 and has touched a high and low of Rs. 203.75 and Rs. 199.00 respectively. So far 32477 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 230.00 on 17-Oct-2017 and a 52 week low of Rs. 155.00 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 216.20 and Rs. 196.25 respectively. The current market cap of the company is Rs. 2543.74 crore.

The promoters holding in the company stood at 60.00%, while institutions and non-institutions held 7.92% and 32.08% respectively.

Suven Life Sciences is participating and presenting positive Pre-clinical and Phase-1 clinical data of several advanced molecules from their portfolio of new chemical entities (NCEs) and the status of Phase 2 clinical trial of their lead compound SUVN-502 at Neuroscience 2017, organized by Society for Neuroscience being held at Washington DC, USA during 13-15 November 2017. These data presentations highlight Suven’s continued commitment to explore new treatment options addressing unmet medical need through novel mechanisms and targets.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

 

Suven Life Sciences Share Price

164.00 -6.15 (-3.61%)
08-Dec-2025 15:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×